New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.The companies, namely Sun Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories, launched their variants a day after Hyderabad-based Natco Pharma launched its generic semaglutide injection in India, priced at Rs 1,290 per month.Sun Pharma launched semaglutide…
Trending
- Bhooth Bangla Review: Akshay Kumar & Priyadarshan Deliver a Wildly Fun Horror-Comedy That Hits All the Right Notes
- Papam Prathap Review: A Wholesome Telugu Village Romance with Heart and Humor
- Toaster Netflix Review: Rajkummar Rao and Sanya Malhotra’s Dark Comedy Is the Most Fun You’ll Have Streaming This Week
- Terror (2026) Kannada Movie Review: Dushyanth Adithya Delivers a Gripping Patriotic Action Thriller
- Toh Ti Ani Fuji Review: A Quietly Devastating Love Story That Lingers Long After It Ends
- The Trap (2026) Review: A Gripping Marathi Psychological Thriller That Pulls You Into Its Dark Web
- TN 2026 Movie Review: A Politically Charged Tamil Satire That Demands Attention
- Manithan Deivamagalam Movie Review: A Heartfelt Rural Drama Rooted in Courage and Community